Seneca Growth Capital VCT plc continues positive momentum

Seneca Growth Capital VCT plc continues positive momentum

Seneca Partners, the specialist SME investment business based in the North-West, has reported that the Seneca Growth Capital VCT has delivered a NAV B share increase from 91.8p to 104.6p in the first six months of the year.

This demonstrates the continued positive momentum for the VCT over the last 15 months, which has seen the NAV per B share increase by 31.6% since March 2020. 

Matt Currie, Investment Director at Seneca Partners commented; “We are pleased that the Seneca Growth Capital VCT continues to achieve positive momentum on the back of growth and realisations in our AIM-quoted investments, such as Skin Biotherapeutics and Polarean Imaging. 

“To capitalise on our track record of AIM investing, we have recently announced the launch of the Seneca AIM EIS Fund, which allows investors to benefit from the inherent tax advantages of both VCTs and EIS.”    


Risk Warning

The value of an investment may go down as well as up, in which case an investor may not get back the amount invested. Past performance is not a guide to future performance. Investors should seek advice from a qualified financial adviser. Nothing on this website should be construed as investment or tax advice.

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.